Related Experiment Video
Updated: Aug 21, 2026

ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer
Quynh N Vo1, Wan-Ju Kim, Luke Cvitanovic
1Department of Biochemistry and Molecular Biology, New Orleans, LA, USA.
Abstract:
Several epidemiological studies on ataxia-telangiectasia families indicate that obligate ATM heterozygotes display an elevated risk for developing breast cancer. However, a molecular basis for a potential link between diminished ATM function and sporadic breast malignancy remains elusive. Here, we show that 78% (18 out of a panel of 23) of surgically removed breast tumors (stage II or greater) displayed aberrant methylation of the ATM proximal promoter region as judged by methylation-specific PCR. Aberrant methylation of the ATM promoter was independently confirmed in several tumors by bisulfite sequencing. Moreover, bisulfite sequencing indicated that this region of the genome is subject to dense methylation. Further, we found a highly significant correlation (P = 0.0006) between reduced ATM mRNA abundance, as measured by real-time RT-PCR, and aberrant methylation of the ATM gene promoter. These findings indicate that epigenetic silencing of ATM expression occurs in locally advanced breast tumors, and establish a link at the molecular level between reduced ATM function and sporadic breast malignancy.
Insights
Aberrant methylation of the ATM gene promoter epigenetically silences ATM expression in advanced breast tumors. This finding links reduced ATM function to sporadic breast cancer, offering a molecular basis for increased breast cancer risk in ATM heterozygotes.
Area of Science:
- Oncology
- Genetics
- Epigenetics
Background:
- Epidemiological studies suggest ATM heterozygotes have increased breast cancer risk.
- The molecular link between diminished ATM function and sporadic breast cancer is not well understood.
Purpose of the Study:
- To investigate the molecular basis of ATM dysfunction in sporadic breast tumors.
- To determine if epigenetic alterations in the ATM gene are associated with breast cancer development.
Main Methods:
- Methylation-specific PCR and bisulfite sequencing were used to analyze ATM promoter methylation in breast tumors.
- Real-time RT-PCR quantified ATM mRNA abundance.
Main Results:
- Aberrant methylation of the ATM proximal promoter region was observed in 78% of stage II or greater breast tumors.
- Dense methylation of the ATM promoter region was confirmed by bisulfite sequencing.
- A significant correlation (P = 0.0006) was found between aberrant ATM promoter methylation and reduced ATM mRNA levels.
Conclusions:
- Epigenetic silencing of ATM expression occurs in locally advanced breast tumors.
- Aberrant ATM promoter methylation provides a molecular link between reduced ATM function and sporadic breast malignancy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...